With a Humanitarian Device Exemption from the Food and Drug Administration, Activa DBS is indicated as an aid in the management of chronic, intractable (drug refractory) primary dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis), for individuals seven years of age and older. By delivering electrical stimulation to the brain, Activa DBS may decrease some symptoms of dystonia.
Developed by Medtronic in collaboration with clinicians and researchers from around the world starting in the 1980s, it ranks as one of the most significant and innovative advances in the treatment of movement disorders.
Activa DBS is the only adjustable, reversible, non-destructive, non-drug treatment for the following movement disorders:
- Parkinson's disease
- Essential Tremor
- Dystonia
